Researchers dig into prescription data to map prostate cancer care

NCT ID NCT07223372

Not yet recruiting Knowledge-focused Sponsor: Bayer Source: ClinicalTrials.gov ↗

Summary

This study looks back at existing prescription records to understand how Australian men with advanced prostate cancer that has spread are being treated. It focuses on newer hormone-blocking drugs and aims to see which treatments are used, who gets them, and how consistently patients take their medication. The goal is to gather real-world insights to help improve future care, but this study does not test a new treatment or involve direct patient contact.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC HORMONESENSITIVE PROSTATE CANCER (MHSPC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.